The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease

被引：0
作者：
Ulf Müller-Ladner
Axel Dignass
Karl Gaffney
Deepak Jadon
Marco Matucci-Cerinic
Triana Lobaton
Philippe Carron
Javier P. Gisbert
Ira Pande
Maximilian Utzinger
Janet Addison
机构：
[1] Justus-Liebig University Giessen,Department of Rheumatology and Clinical Immunology
[2] Goethe University,Department of Medicine I, Agaplesion Markus Hospital
[3] Norfolk and Norwich University Hospitals NHS Foundation Trust,Rheumatology Department
[4] University of Cambridge,Rheumatology Research Unit, Department of Medicine
[5] University of Florence,Department of Internal Medicine
[6] UNIRAR,Department of Internal Medicine and Pediatrics
[7] Hospital San Raffaele,Department of Gastroenterology
[8] Ghent University,Department of Rheumatology
[9] University Hospital Ghent,Molecular Immunology and Inflammation Unit, Center for Inflammation Research
[10] Ghent University Hospital,Department of Internal Medicine and Pediatrics
[11] VIB-UGent,Gastroenterology Unit
[12] Ghent University,Department of Rheumatology
[13] Hospital Universitario de La Princesa,undefined
[14] Instituto de Investigación Sanitaria Princesa (IIS-Princesa),undefined
[15] Universidad Autónoma de Madrid (UAM),undefined
[16] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD),undefined
[17] Nottingham University Hospitals NHS Trust,undefined
[18] Biogen GmbH,undefined
[19] Biogen Idec,undefined
来源：
BioDrugs | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：873 / 889
页数：16
相关论文
共 157 条
  • [1] Brennan FM(2008)Evidence that cytokines play a role in rheumatoid arthritis J Clin Invest 118 3537-3545
  • [2] McInnes IB(2011)Psoriatic arthritis: update on pathophysiology, assessment and management Ann Rheum Dis 70 i77-68
  • [3] Mease PJ(2016)Cytokines in rheumatoid arthritis—shaping the immunological landscape Nat Rev Rheumatol 12 63-1006
  • [4] McInnes IB(2018)The early phases of ankylosing spondylitis: emerging insights from clinical and basic science Front Immunol 9 2668-639
  • [5] Buckley CD(2019)Cytokine networks in the pathophysiology of inflammatory bowel disease Immunity 50 992-61
  • [6] Isaacs JD(2021)Reframing immune-mediated inflammatory diseases through signature cytokine hubs N Engl J Med 385 628-48
  • [7] Watad A(2021)Adalimumab biosimilars in the treatment of rheumatoid arthritis: a systematic review of the evidence for biosimilarity Rheumatol Ther. 8 41-3745
  • [8] Bridgewood C(2014)Adalimumab in the treatment of immune-mediated diseases Int J Immunopathol Pharmacol 27 33-12.e3
  • [9] Russell T(2020)Unlocking the value of anti-TNF biosimilars: reducing disease burden and improving outcomes in chronic immune-mediated inflammatory diseases: a narrative review Adv Ther 37 3732-79
  • [10] Marzo-Ortega H(2022)The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems Semin Arthritis Rheum 52 151939-1250
12345678910